Cytomegalovirus infection of bile duct epithelial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of liver grafts

Journal of Hepatology

Volumn 31, Issue 5, 1999, Pages 913-920

  Evans, Paul C ^a   Coleman, Nick ^a   Wreghitt, Tim G ^a   Wight, Derek G D ^a   Alexander, Graeme J M ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Chronic rejection; Cytomegalovirus; In situ hybridisation; Liver; Transplantation

Indexed keywords

ARTERY THROMBOSIS; ARTICLE; BILE DUCT OBSTRUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; ENDOTHELIUM CELL; EPITHELIUM CELL; GRAFT FAILURE; GRAFT INFECTION; GRAFT REJECTION; GRAFT SURVIVAL; HEPATIC ARTERY; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER CELL; LIVER TRANSPLANTATION; MONONUCLEAR CELL; NEEDLE BIOPSY; PRIORITY JOURNAL; SEROCONVERSION;

EID: 0032696719     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80294-3     Document Type: Article

References (36)

1. Candinas D, Gunson BK, Nightingale P, Hubscher S, McMaster P, Neuberger JM. Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet. 346:1995;1117-1121.
2. O'Grady JG, Sutherland S, Harvey F, Calne RY, Alexander GJM, Donaldson PT, et al. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile duct syndrome after liver transplantation. Lancet. ii:1988;302-305.
3. Manez R, White LT, Linden P, Kusne S, Martin M, Kramer D, et al. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation. 55:1993;1067-1071.
4. Arnold JC, Portmann BC, O'Grady JG, Naoumov NV, Alexander GJM, Williams R. Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome. Hepatology. 16:1992;285-292.
5. Donaldson PT, O'Grady J, Portmann B, Davis H, Alexander GJM, Neuberger J, et al. Evidence for an immune response to class I antigens in the vanishing bile duct syndrome after liver transplantation. Lancet. 1:1987;945-948.
6. Markus BH, Duquesnoy RJ, Gordon RD, Fung JJ, Vanek M, Klintmalm G, et al. Histocompatibility and liver transplant outcome: does HLA exert a dualistic effect? Transplant. 46:1988;372-377.
7. Hubscher SG. Histological findings in liver allograft rejection - new insights into the pathogenesis of hepatocellular damage in liver allografts. Histopathology. 18:1991;377-383.
8. O'Grady JG, Williams R. Immunology of liver transplantation. Targan SR, Shanahan F. Immunology and Immunopathology of the Liver and Gastrointestinal Tract. 1989;319-331 Igaku-Shoin, Tokyo.
9. Singh N, Dummer JS, Kusne S, Breinig NK, Armstrong JA, Makowa L, et al. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and effect of OKT3 antibodies. J Infect Dis. 158:1988;124-131.
10. Balfour HH, Heussner RC. Cytomegalovirus infections and liver transplantation - an overview. Transplant Proc. 25:1993;2012-2013.
11. Sutherland S, Bracken P, Wreghitt TG, O'Grady J, Calne RY, Williams R. Donated organ as a source of cytomegalovirus in orthotopic liver transplantation. J Med Virol. 37:1992;170-173.
12. Saliba F, Gugenheim D, Samuel D, Bismuth A, Mathieu D, Serres C, et al. Incidence of cytomegalovirus infection and effects of cytomegalovirus immune globulin prophylaxis after orthotopic liver transplantation. Transplant Proc. 19:1987;4081-4082.
13. Converse PJ, Hess AD, Tutschka PJ, Santos PW. Effect of cyclosporine on the response of normal human lymphocytes to cytomegalovirus in vitro. Infect Immun. 41:1983;1226-1233.
14. Fox AS, Tolpin MD, Baker AL, Broelsch CE, Whittington PJ, Jackson T, et al. Seropositivity in liver transplant recipients as a predictor of cytomegalovirus disease. J Infect Dis. 157:1988;383-385.
15. Stratta RJ, Schaeffer MS, Markin RS, Wood RP, Langnas AN, Reed EC, et al. Cytomegalovirus infection and disease after liver transplantation: an overview. Dig Dis Sci. 37:1992;673-688.
16. O'Grady JG, Alexander GJM, Sutherland S, Donaldson P, Harvey F, Portmann B, et al. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile duct syndrome after liver transplantation. Lancet. ii:1988;302-305.
17. Lautenschlager I, Hörstedt, Jalanko H, Loginov R, Salmela K, Taskinen E, et al. Persistent cytomegalovirus in liver allografts with chronic rejection. Hepatology. 25:1997;190-194.
18. Patterson JW, Broecker AH, Kornstein MJ, Mills AS. Cutaneous cytomegalovirus infection in a liver transplant patient. Diagnosis by in situ DNA hybridisation. Am J Dermatopathol. 10:1988;524-530.
19. Markovic Lipkovski J, Muller CA, EnglerBlum G, Strutz F, Kuhn W, Risler T, et al. Human cytomegalovirus in rejected kidney grafts; detection by polymerase chain reaction. Nephrol Dial Transplant. 7:1992;865-870.
20. Van Dorp WT, Jonges E, Bruggeman CA, Daha MR, Vanes LA, Vanderwoude FJ. Direct induction of MHC class I, but not class II, expression on endothelial cells by cytomegalovirus infection. Transplant. 48:1989;469-472.
21. Hosenpud JD, Chou S, Wagner CR. Cytomegalovirus-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells. Transplant. 52:1991;896-903.
22. Schafer P, Braun RW, Mohring K, Henco K, Kang J, Wendland T, et al. Quantitative determination of human cytomegalovirus target sequences in peripheral blood leukocytes by nested polymerase chain reaction and temperature gradient gel electrophoresis. J Gen Virol. 74:1993;2699-2707.
23. Shaw SB, Rasmussen RD, McDonough SH, Staprans SI, Vacquier JP, Spector DH. Cell related sequences in the DNA genome of human cytomegalovirus strain AD169. J Virol. 55:1985;843-848.
24. Ruger R, Bornkamm GW, Fleckenstein B. Human cytomegalovirus DNA sequences with homologies to the cellular genome. J Gen Virol. 65:1984;1351-1364.
25. Evans PC, Gray J, Wreghitt TG, Marcus RE, Alexander GJM. Comparison of three polymerase chain reaction (PCR) techniques for detecting cytomegalovirus DNA in serum: comparison with detection of early antigen fluorescent foci (DEAFF) and culture. J Med Microbiol. 1999;. in press.
26. Evans PC, Gray J, Wreghitt TG, Alexander GJM. Optimisation of the polymerase chain reaction and dot-blot hybridisation for detecting cytomegalovirus DNA in urine: comparison with detection of early antigen fluorescent foci and culture. J Virol Methods. 73:1998;41-52.
27. Naoumov NV, Alexander GJM, O'Grady JG, Aldis P, Portmann B, Williams R, et al. Rapid diagnosis of cytomegalovirus infection by in situ hybridisation in liver grafts. Lancet. i:1988;1361-1364.
28. Naoumov NV, Alexander GJM, Eddleston ALWF, Williams R. In situ hybridisation in formalin fixed, paraffin wax embedded liver specimens: method for detecting human and viral DNA using biotinylated probes. J Clin Pathol. 41:1988;793-798.
29. Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol. 72:1991;2059-2064.
30. Paya CV, Weisner RH, Hermans PE, Larson Keller JJ, Ilstrup DM, Krom RAF, et al. Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation. Hepatology. 16:1992;66-70.
31. Van Dorp WT, Jonges E, Bruggeman CA, Daha MR, Vanes LA, Vanderwoude FJ. Direct induction of MHC class I, but not class II, expression on endothelial cells by cytomegalovirus infection. Transplantation. 48:1989;469-472.
32. Ouwehand AJ, Back AHMM, Baan CC, Vaessen LMB, Jutte NHPM, Bos E, et al. Cytomegalovirus infection and allo specific cytotoxic activity of graft infiltrating cells after heart transplantation. J Med Virol. 42:1994;175-181.
33. Craigen JL, Grundy JE. Cytomegalovirus induced upregulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment. Transplantation. 62:1996;1102-1108.
34. Fabricant CG, Fabricant J, Minick CR, Litrenta MM. Herpes virus induced atherosclerosis in chickens. Fed Proc. 42:1983;2476-2479.
35. Wu TC, Hruban RH, Ambinder RF, Pizzorno M, Cameron DE, Baumgartner WA, et al. Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. Am J Pathol. 140:1992;739-747.
36. Melnick JL, Adam E, Debakey ME. Cytomegalovirus and atherosclerosis. Bioessays. 17:1995;899-903.